Novavax Inc. (NVAX)
NASDAQ: NVAX
· Real-Time Price · USD
7.04
0.10 (1.44%)
At close: Jun 16, 2025, 3:59 PM
7.01
-0.36%
After-hours: Jun 16, 2025, 07:59 PM EDT
1.44% (1D)
| Bid | 6.99 |
| Market Cap | 1.14B |
| Revenue (ttm) | 1.25B |
| Net Income (ttm) | 478.7M |
| EPS (ttm) | 2.75 |
| PE Ratio (ttm) | 2.56 |
| Forward PE | 19.8 |
| Analyst | Buy |
| Ask | 7.01 |
| Volume | 3,850,804 |
| Avg. Volume (20D) | 8,590,265 |
| Open | 7.04 |
| Previous Close | 6.94 |
| Day's Range | 6.88 - 7.11 |
| 52-Week Range | 5.01 - 17.81 |
| Beta | 2.77 |
About NVAX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NVAX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NVAX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 weeks ago
-0.78%
Shares of vaccine stocks are trading higher follow...
Unlock content with
Pro Subscription
4 weeks ago
+15.01%
Moderna shares are trading higher after the company announced it received approval from the FDA for its COVID-19 vaccine and unlocked a milestone $175 million payment from Sanofi SA.
